國立虎尾科技大學 |

Oncological PET/CT with Histological Confirmation

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Oncological PET/CT with Histological Confirmation/ edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke.
other author:	Cerci, Juliano.
Description:	VII, 97 p. 53 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Nuclear medicine. -
Online resource:	https://doi.org/10.1007/978-3-319-27880-3
ISBN:	9783319278803

Oncological PET/CT with Histological Confirmation
Oncological PET/CT with Histological Confirmation[electronic resource] /edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke. - 1st ed. 2016. - VII, 97 p. 53 illus. in color.online resource.

PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging.- FDG PET/CT to guide biopsy: methods.- FDG PET/CT to guide biopsy: type of acess.- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma.- FDG PET/CT to guide biopsy in lymphoma: results.- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions.- FDG PET/CT to guide biopsy in pancreatic lesions: results.- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions.- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results.

This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.

ISBN: 9783319278803

Standard No.: 10.1007/978-3-319-27880-3doiSubjects--Topical Terms:

673902
Nuclear medicine.

LC Class. No.: R895-920

Dewey Class. No.: 616.07548

Oncological PET/CT with Histological Confirmation
LDR:02935nam a22003975i 4500 001 979032
003 DE-He213
005 20200703234721.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319278803 $9 978-3-319-27880-3
024 7 $a 10.1007/978-3-319-27880-3 $2 doi
035 $a 978-3-319-27880-3
050 4 $a R895-920
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.07548 $2 23
245 1 0 $a Oncological PET/CT with Histological Confirmation $h [electronic resource] / $c edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a VII, 97 p. 53 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging.- FDG PET/CT to guide biopsy: methods.- FDG PET/CT to guide biopsy: type of acess.- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma.- FDG PET/CT to guide biopsy in lymphoma: results.- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions.- FDG PET/CT to guide biopsy in pancreatic lesions: results.- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions.- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results.
520 $a This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.
650 0 $a Nuclear medicine. $3 673902
650 0 $a Oncology . $3 1253469
650 0 $a Pathology. $3 668553
650 1 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Oncology. $3 593951
700 1 $a Cerci, Juliano. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1107167
700 1 $a Fanti, Stefano. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 796628
700 1 $a Delbeke, Dominique. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1107168
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319278780
776 0 8 $i Printed edition: $z 9783319278797
776 0 8 $i Printed edition: $z 9783319802336
856 4 0 $u https://doi.org/10.1007/978-3-319-27880-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)